科言猫
学术研究的AI总结
首页
文献互助
订阅
我的收藏
科研工具
选题分析
论文总结
专利管理
未登录
返回
J
James E. Frampton
Imperial College London
48
H指数
196
论文数
6.8K
被引数
0
相关解读
订阅
收录论文
136
发表时间
发表时间
IF
被引数
Investigating the effects of mycoprotein and guar gum on postprandial glucose in type 2 diabetes: a double-blind randomised controlled trial
探究菌蛋白和瓜尔豆胶对2型糖尿病患者餐后血糖的影响:一项双盲随机对照试验
NUTRITION & DIABETES
IF
5.2
2025-05-23
0
OA
AI
Anna Cherta-Murillo; Kexin Zhou; Martina Tashkova; James Frampton; Ana Cláudia Cepas de Oliveira; Claire Ho; Georgia Franco-Becker; Edward S. Chambers; Anne Dornhorst; Gary S. Frost
分享
收藏
Effects of Acute Exercise and Carbohydrate Intake on Plasma GDF-15 Levels and Its Association With Appetite Regulation
JOURNAL OF THE ENDOCRINE SOCIETY
IF
3.1
2025-01-18
0
OA
AI
James, Ellen; Frampton, James; Murphy, Kevin G.; Chambers, Edward S.
分享
收藏
Ivosidenib: A Review in Advanced Cholangiocarcinoma (vol 18, pg 973, 2023)
TARGETED ONCOLOGY
IF
4
2024-10-22
0
OA
AI
Frampton, James E.
分享
收藏
Pemigatinib: A Review in Advanced Cholangiocarcinoma
TARGETED ONCOLOGY
IF
4
2024-01-11
1
PRE
AI
Frampton, James E.
分享
收藏
Ivosidenib: A Review in Advanced Cholangiocarcinoma
TARGETED ONCOLOGY
IF
4
2023-10-19
4
OA
AI
Frampton, James E.
分享
收藏
Epcoritamab: First Approval
DRUGS
IF
14.4
2023-08-19
14
PRE
AI
Frampton, James E.
分享
收藏
Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes (vol 83, pg 923, 2023)
DRUGS
IF
14.4
2023-07-01
1
OA
AI
Frampton, James E.
分享
收藏
Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes
DRUGS
IF
14.4
2023-06-15
14
OA
AI
Frampton, James E.
分享
收藏
Empagliflozin: A Review in Symptomatic Chronic Heart Failure
DRUGS
IF
14.4
2022-11-14
14
PRE
AI
Frampton, James E.
分享
收藏
Darinaparsin: First Approval (Nov, 10.1007/s40265-022-01795-z, 2022)
DRUGS
IF
14.4
2022-11-14
0
OA
AI
Frampton, James E.
分享
收藏
Darinaparsin: First Approval
DRUGS
IF
14.4
2022-11-04
14
PRE
AI
Frampton, James E.
分享
收藏
Varenicline Solution Nasal Spray: A Review in Dry Eye Disease
DRUGS
IF
14.4
2022-10-05
17
OA
AI
Frampton, James E.
分享
收藏
Teserpaturev/G47Δ: First Approval
Teserpaturev/G47Δ: 首次批准
BIODRUGS
IF
6.9
2022-09-13
55
PRE
AI
Frampton, James E.
分享
收藏
Osimertinib: A Review in Completely Resected, Early-Stage, EGFR Mutation-Positive NSCLC
TARGETED ONCOLOGY
IF
4
2022-06-17
8
PRE
AI
Frampton, James E.
分享
收藏
Efmoroctocog Alfa: A Review in Haemophilia A (vol 81, pg 2035, 2021)
DRUGS
IF
14.4
2021-12-01
1
OA
AI
Frampton, James E.
分享
收藏
Efmoroctocog Alfa: A Review in Haemophilia A
DRUGS
IF
14.4
2021-11-07
14
OA
AI
Frampton, James E.
分享
收藏
Isatuximab: A Review of Its Use in Multiple Myeloma (vol 16, pg 675, 2021)
TARGETED ONCOLOGY
IF
4
2021-10-08
0
OA
AI
Frampton, James E.
分享
收藏
Higher dietary fibre intake is associated with increased skeletal muscle mass and strength in adults aged 40 years and older
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
IF
9.1
2021-09-29
40
OA
AI
Frampton, James; Murphy, Kevin G.; Frost, Gary; Chambers, Edward S.
分享
收藏
Finerenone: First Approval
DRUGS
IF
14.4
2021-09-14
43
PRE
AI
Frampton, James E.
分享
收藏
Isatuximab: A Review of Its Use in Multiple Myeloma
TARGETED ONCOLOGY
IF
4
2021-08-05
33
OA
AI
Frampton, James E.
分享
收藏
研究方向
暂时未获取到该数据
合作学者
合作期刊
S
Stephen D. Silberstein
H 指数: 100 · 论文数: 869
R
Rex N. Brogden
H 指数: 99 · 论文数: 286
G
GriffinBruce
(Gary Frost)
H 指数: 94 · 论文数: 667
K
Karen L. Goa
H 指数: 90 · 论文数: 352
G
Gillian M. Keating
H 指数: 73 · 论文数: 466
查看更多